Keytruda Qlex pembrolizumab 395 mg and berahyaluronidase alfa 4,800 units per 2.4 mL (165 mg/2,000 units per mL) injection Images

Generic Name: berahyaluronidase alfa/pembrolizumab

This medication has been identified as Keytruda Qlex pembrolizumab 395 mg and berahyaluronidase alfa 4,800 units per 2.4 mL (165 mg/2,000 units per mL) injection and is used for Biliary Tract Tumor, Breast Cancer, Cervical Cancer, Colorectal Cancer, and Endometrial Cancer. It

Images of medication

Keytruda Qlex

Generic Name

berahyaluronidase alfa/pembrolizumab

Strength

pembrolizumab 395 mg and berahyaluronidase alfa 4,800 units per 2.4 mL (165 mg/2,000 units per mL) injection

Availability

Prescription only

CSA Schedule

Unknown

Labeler / Supplier

Merck

National Drug Code (NDC)

00006-3083

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer